Literature DB >> 24825399

Minireview: pioneer transcription factors in cell fate specification.

Jacques Drouin1.   

Abstract

The specification of cell fate is critical for proper cell differentiation and organogenesis. In endocrine tissues, this process leads to the differentiation, often a multistep process, of hormone-producing cells. This process is driven by a combination of transcription factors (TFs) that includes general factor, tissue-restricted, and/or cell-restricted factors. The last 2 decades have seen the discovery of many TFs of restricted expression and function in endocrine tissues. These factors are typically critical for expression of hormone-coding genes as well as for differentiation and proper function of hormone-producing cells. Further, genes encoding these tissue-restricted TFs are themselves subject to mutations that cause hormone deficiencies. Although the model that emerged from these 2 decades is one in which a specific combination of TFs drives a unique cell specification and genetic program, recent findings have led to the discovery of TFs that have the unique property of being able to remodel chromatin and thus modify the epigenome. Most importantly, such factors, known as pioneer TFs, appear to play critical roles in programming the epigenome during the successive steps involved in cell specification. This review summarizes our current understanding of the mechanisms for pioneer TF remodeling of chromatin. Currently, very few TFs that have proven pioneer activity are known, but it will be critical to identify these factors and understand their mechanisms of action if we are to harness the potential of regenerative therapies in endocrinology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24825399      PMCID: PMC5414827          DOI: 10.1210/me.2014-1084

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  70 in total

1.  FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription.

Authors:  Mathieu Lupien; Jérôme Eeckhoute; Clifford A Meyer; Qianben Wang; Yong Zhang; Wei Li; Jason S Carroll; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2008-03-21       Impact factor: 41.582

Review 2.  Transcriptional regulation by Polycomb group proteins.

Authors:  Luciano Di Croce; Kristian Helin
Journal:  Nat Struct Mol Biol       Date:  2013-10       Impact factor: 15.369

3.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

Review 4.  Gene regulatory networks and transcriptional mechanisms that control myogenesis.

Authors:  Margaret Buckingham; Peter W J Rigby
Journal:  Dev Cell       Date:  2014-02-10       Impact factor: 12.270

5.  Hormone-responsive enhancer-activity maps reveal predictive motifs, indirect repression, and targeting of closed chromatin.

Authors:  Daria Shlyueva; Christoph Stelzer; Daniel Gerlach; J Omar Yáñez-Cuna; Martina Rath; Łukasz M Boryń; Cosmas D Arnold; Alexander Stark
Journal:  Mol Cell       Date:  2014-03-27       Impact factor: 17.970

6.  Enhancer-associated H3K4 monomethylation by Trithorax-related, the Drosophila homolog of mammalian Mll3/Mll4.

Authors:  Hans-Martin Herz; Man Mohan; Alexander S Garruss; Kaiwei Liang; Yoh-Hei Takahashi; Kristen Mickey; Olaf Voets; C Peter Verrijzer; Ali Shilatifard
Journal:  Genes Dev       Date:  2012-11-19       Impact factor: 11.361

7.  Histone H2A.Z is essential for estrogen receptor signaling.

Authors:  Nicolas Gévry; Sara Hardy; Pierre-Etienne Jacques; Liette Laflamme; Amy Svotelis; François Robert; Luc Gaudreau
Journal:  Genes Dev       Date:  2009-06-10       Impact factor: 11.361

8.  Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

Authors:  Qianben Wang; Wei Li; Yong Zhang; Xin Yuan; Kexin Xu; Jindan Yu; Zhong Chen; Rameen Beroukhim; Hongyun Wang; Mathieu Lupien; Tao Wu; Meredith M Regan; Clifford A Meyer; Jason S Carroll; Arjun Kumar Manrai; Olli A Jänne; Steven P Balk; Rohit Mehra; Bo Han; Arul M Chinnaiyan; Mark A Rubin; Lawrence True; Michelangelo Fiorentino; Christopher Fiore; Massimo Loda; Philip W Kantoff; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

9.  Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency.

Authors:  Anne-Marie Pulichino; Sophie Vallette-Kasic; Catherine Couture; Yves Gauthier; Thierry Brue; Michel David; Georges Malpuech; Cheri Deal; Guy Van Vliet; Monique De Vroede; Felix G Riepe; Carl-Joachim Partsch; Wolfgang G Sippell; Merih Berberoglu; Begüm Atasay; Jacques Drouin
Journal:  Genes Dev       Date:  2003-03-15       Impact factor: 11.361

10.  Isolation of active regulatory elements from eukaryotic chromatin using FAIRE (Formaldehyde Assisted Isolation of Regulatory Elements).

Authors:  Paul G Giresi; Jason D Lieb
Journal:  Methods       Date:  2009-03-18       Impact factor: 3.608

View more
  22 in total

Review 1.  Pituitary Medicine From Discovery to Patient-Focused Outcomes.

Authors:  Shlomo Melmed
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

2.  Nuclear localization signal region in nuclear receptor PXR governs the receptor association with mitotic chromatin.

Authors:  Manjul Rana; Amit K Dash; Kalaiarasan Ponnusamy; Rakesh K Tyagi
Journal:  Chromosome Res       Date:  2018-07-15       Impact factor: 5.239

3.  Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression.

Authors:  Duojiao Chen; Taylor M Parker; Poornima Bhat-Nakshatri; Xiaona Chu; Yunlong Liu; Yue Wang; Harikrishna Nakshatri
Journal:  Oncogene       Date:  2021-01-08       Impact factor: 9.867

Review 4.  Sequence and chromatin determinants of transcription factor binding and the establishment of cell type-specific binding patterns.

Authors:  Divyanshi Srivastava; Shaun Mahony
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-10-19       Impact factor: 4.490

5.  Developmental Control of NRAMP1 (SLC11A1) Expression in Professional Phagocytes.

Authors:  Mathieu F M Cellier
Journal:  Biology (Basel)       Date:  2017-05-03

Review 6.  Chromatin reprogramming in breast cancer.

Authors:  Erin E Swinstead; Ville Paakinaho; Gordon L Hager
Journal:  Endocr Relat Cancer       Date:  2018-04-24       Impact factor: 5.678

Review 7.  Reprogramming of cell fate: epigenetic memory and the erasure of memories past.

Authors:  Buhe Nashun; Peter W S Hill; Petra Hajkova
Journal:  EMBO J       Date:  2015-03-27       Impact factor: 11.598

Review 8.  Pioneer transcription factors in cell reprogramming.

Authors:  Makiko Iwafuchi-Doi; Kenneth S Zaret
Journal:  Genes Dev       Date:  2014-12-15       Impact factor: 11.361

Review 9.  LEAFY, a Pioneer Transcription Factor in Plants: A Mini-Review.

Authors:  Nobutoshi Yamaguchi
Journal:  Front Plant Sci       Date:  2021-07-05       Impact factor: 5.753

10.  AP-1 imprints a reversible transcriptional programme of senescent cells.

Authors:  Ricardo Iván Martínez-Zamudio; Pierre-François Roux; José Américo N L F de Freitas; Lucas Robinson; Gregory Doré; Bin Sun; Dimitri Belenki; Maja Milanovic; Utz Herbig; Clemens A Schmitt; Jesús Gil; Oliver Bischof
Journal:  Nat Cell Biol       Date:  2020-06-08       Impact factor: 28.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.